Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3302834

C[SiH2][Zr](c1ccccc1)(C1C=Cc2ccccc21)C1C=Cc2ccccc21.Cl.Cl

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 6/20 0.32
HTR6 known ✓ P50406 1/20 0.30
HTR2A known ✓ P28223 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
PMP22 Q01453 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8734897 0.98 SIGMAR1 (0.33) SIGMAR1HTR6HTR2A
Hydrochloric Acid SCHEMBL3304636 0.80 HTR6 (0.31) HTR6
SCHEMBL8731744 0.78 HTR6 (0.32) HTR6
SCHEMBL8755168 0.75 HTR2A (0.35) SIGMAR1HTR6HTR2A
SCHEMBL5276701 0.75 HTR2A (0.35) SIGMAR1HTR6KDM4EMEN1PMP22
Hydrochloric Acid SCHEMBL5926290 0.75 SIGMAR1 (0.32) SIGMAR1HTR6KDM4EMEN1PMP22
Hydrochloric Acid SCHEMBL5695978 0.75 HTR6 (0.33) SIGMAR1HTR6HTR2A
Hydrochloric Acid SCHEMBL7945370 0.75 SIGMAR1 (0.33) SIGMAR1HTR6HTR2A
Hydrochloric Acid SCHEMBL5179760 0.75 HTR6 (0.33) SIGMAR1HTR6HTR2A
Hydrochloric Acid SCHEMBL7640926 0.75 HTR6 (0.33) SIGMAR1HTR6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597632-B1 NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY LG CHEMICAL LTD (KR) 2013-03-27 EP claimed
US-8329841-B2 Photoreactive polymer and method for preparing the same LG CHEM, LTD. (KR) 2012-12-11 US claimed
US-20120149848-A1 PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME LG CHEM, LTD. (KR) 2012-06-14 US claimed
US-20100093955-A1 PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME LG CHEM, LTD. (KR) 2010-04-15 US claimed
EP-1597632-A4 NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY LG CHEMICAL LTD (KR) 2009-08-26 EP claimed
WO-2008115028-A1 PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME LG CHEM, LTD. (KR) 2008-09-25 WO claimed
US-7378206-B2 Non-magnetic monocomponent positive toner composition having superior transfer efficiency LG CHEM, LTD. (KR) 2008-05-27 US claimed
US-20060105260-A1 Non-magnetic monocomponent positive toner composition having superior transfer efficiency LG CHEM, LTD. (KR) 2006-05-18 US claimed
EP-1597632-A1 NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY LG Chem, Ltd. (KR) 2005-11-23 EP claimed
WO-2004079456-A1 NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY LG CHEM, LTD. (KR) 2004-09-16 WO claimed
US-6641925-B1 Metallocene system catalyzed cycloolefin copolymer laminated to polyvinyl chloride; extrusion coated film as packaging TICONA GMBH (DE) 2003-11-04 US claimed
EP-0791611-B1 Process for the preparation of cycloolefin polymers TICONA GMBH (DE) 2003-02-12 EP claimed
US-5914376-A Catalyst for the polymerization of olefins, process for the preparation thereof, and use thereof TARGOR GMBH (DE) 1999-06-22 US claimed
EP-0615981-B1 Supported catalyst system, its preparation and its use in olefin polymerisation TARGOR GMBH (DE) 1998-05-06 EP claimed
EP-0610852-B1 Process for preparing cyclo-olefin polymers HOECHST AG (DE) 1997-05-07 EP claimed
US-5545829-A Process for preparing cycloolefin copolymers HOECHST AKTIENGESELLSCHAFT (DE) 1996-08-13 US claimed
EP-1597632-B1 NON-MAGNETIC MONOCOMPONENT POSITIVE TONER COMPOSITION HAVING SUPERIOR TRANSFER EFFICIENCY LG CHEMICAL LTD (KR) 2013-03-27 EP disclosed
US-8329841-B2 Photoreactive polymer and method for preparing the same LG CHEM, LTD. (KR) 2012-12-11 US disclosed
EP-0567952-A1 Olefin polymerization catalyst, process for its preparation, and its use HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed
US-5087677-A Catalyst of a metallocene and an aluminoxane HOECHST AKTIENGESELLSCHAFT (DE) 1992-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149848-A1 PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME PCNA, LCP1, CCND2 SIGMAR1 4485/4885HTR6 3377/4885HTR2A 3002/4885
US-20100093955-A1 PHOTOREACTIVE POLYMER AND METHOD FOR PREPARING THE SAME PCNA, LCP1, CCND2 SIGMAR1 4485/4885HTR6 3377/4885HTR2A 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.